Relugolix - HY-16474
Nur noch %1 verfügbar
Catalog #
HY-16474
Ab
72,00 €
Relugolix (TAK-385)?is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209)[1]. Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al[2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-16474/Relugolix-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | TAK-385 |
| CAS | 737789-87-6 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 623.63 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | GnRH Receptor |
| Application: | Cancer-programmed cell death |
|---|